Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Journal for Immunotherapy of Cancer
|
April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Nature Photonics
|
October 1, 2009
Dynamic manipulation and separation of individual semiconducting and metallic nanowires
Arash Jamshidi, Peter J Pauzauskie, P James Schuck, et al.
Neonatology
|
November 14, 2017
BMI Is a Better Body Proportionality Measure than the Ponderal Index and Weight-for-Length for Preterm Infants
A Nicole Ferguson, Shannon C Grabich, Irene E Olsen, et al.
Targeted Oncology
|
October 25, 2021
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E Grilley-Olson, et al.
JAMA Oncology
|
May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial
Melissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer
Jeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Plos One
|
November 27, 2013
Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice
Jeffrey Chou, Matthew P Fitzgibbon, Christie-Lynn L Mortales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2016
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov, Mohammed M Milhem, David Minor, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 15, 2020
Airway profile of bioactive lipids predicts early progression of lung disease in cystic fibrosis
Hamed Horati, Hettie M Janssens, Camilla Margaroli, et al.
Plos One
|
March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Seth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Journal for Immunotherapy of Cancer
|
April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Nature Photonics
|
October 1, 2009
Dynamic manipulation and separation of individual semiconducting and metallic nanowires
Arash Jamshidi, Peter J Pauzauskie, P James Schuck, et al.
Neonatology
|
November 14, 2017
BMI Is a Better Body Proportionality Measure than the Ponderal Index and Weight-for-Length for Preterm Infants
A Nicole Ferguson, Shannon C Grabich, Irene E Olsen, et al.
Targeted Oncology
|
October 25, 2021
Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
Siwen Hu-Lieskovan, Fadi Braiteh, Juneko E Grilley-Olson, et al.
JAMA Oncology
|
May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial
Melissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer
Jeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Plos One
|
November 27, 2013
Phenotypic and transcriptional fidelity of patient-derived colon cancer xenografts in immune-deficient mice
Jeffrey Chou, Matthew P Fitzgibbon, Christie-Lynn L Mortales, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2016
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
Igor Puzanov, Mohammed M Milhem, David Minor, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
February 15, 2020
Airway profile of bioactive lipids predicts early progression of lung disease in cystic fibrosis
Hamed Horati, Hettie M Janssens, Camilla Margaroli, et al.
Plos One
|
March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine
Seth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
Page
of 3